Potassium Citrate Tablet, Extended Release
Product Images NDC 70518-4477

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 70518-4477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text provides information about a Potassium Citrate Tablet in extended-release form containing 10 mEq {1080 mg}. The package contains 100 tablets with a yellow T400 capsule color. The NDC number for the product is 70518-4477-00, and it is manufactured by Camber Pharma, Inc. The medication should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). Additionally, the text includes contact information for RemedyRepack Inc. for repackaging and states to keep the medication out of reach of children.*

FDA Label Image

Structure (Structure)

FDA Label Image

Table 1. (Table 1.)

This is a table showing the effect of Potassium Citrate in patients with Calcium Oxalate Nephrolithiasis based on the number of stones formed per year in different groups. The baseline number of stones, number on treatment, remission percentage, and any decrease percentage are provided for each group. Remission is defined as the percentage of patients remaining free of newly formed stones during treatment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.